247 related articles for article (PubMed ID: 22291585)
1. Single sample expression-anchored mechanisms predict survival in head and neck cancer.
Yang X; Regan K; Huang Y; Zhang Q; Li J; Seiwert TY; Cohen EE; Xing HR; Lussier YA
PLoS Comput Biol; 2012 Jan; 8(1):e1002350. PubMed ID: 22291585
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor.
De Cecco L; Bossi P; Locati L; Canevari S; Licitra L
Ann Oncol; 2014 Aug; 25(8):1628-35. PubMed ID: 24827125
[TBL] [Abstract][Full Text] [Related]
3. Towards mechanism classifiers: expression-anchored Gene Ontology signature predicts clinical outcome in lung adenocarcinoma patients.
Yang X; Li H; Regan K; Li J; Huang Y; Lussier YA
AMIA Annu Symp Proc; 2012; 2012():1040-9. PubMed ID: 23304380
[TBL] [Abstract][Full Text] [Related]
4. Curation-free biomodules mechanisms in prostate cancer predict recurrent disease.
Chen JL; Hsu A; Yang X; Li J; Lee Y; Parinandi G; Li H; Lussier YA
BMC Med Genomics; 2013; 6 Suppl 2(Suppl 2):S4. PubMed ID: 23819917
[TBL] [Abstract][Full Text] [Related]
5. Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients.
Huang Y; Liu Z; Zhong L; Wen Y; Ye Q; Cao D; Li P; Liu Y
BMC Genomics; 2020 Oct; 21(1):691. PubMed ID: 33023466
[TBL] [Abstract][Full Text] [Related]
6. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.
Chung CH; Parker JS; Ely K; Carter J; Yi Y; Murphy BA; Ang KK; El-Naggar AK; Zanation AM; Cmelak AJ; Levy S; Slebos RJ; Yarbrough WG
Cancer Res; 2006 Aug; 66(16):8210-8. PubMed ID: 16912200
[TBL] [Abstract][Full Text] [Related]
8. Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma.
Bayo P; Jou A; Stenzinger A; Shao C; Gross M; Jensen A; Grabe N; Mende CH; Rados PV; Debus J; Weichert W; Plinkert PK; Lichter P; Freier K; Hess J
Mol Oncol; 2015 Oct; 9(8):1704-19. PubMed ID: 26040981
[TBL] [Abstract][Full Text] [Related]
9. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
10. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
Song D; Tian J; Han X; Li X
Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of WD repeat domain 5 associates with aggressive clinicopathological features and unfavorable prognosis in head neck squamous cell carcinoma.
Wu Y; Diao P; Li Z; Zhang W; Wang D; Wang Y; Cheng J
J Oral Pathol Med; 2018 May; 47(5):502-510. PubMed ID: 29569374
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel therapeutic target for head and neck squamous cell carcinomas: a role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway.
Shimizu S; Tsukada J; Sugimoto T; Kikkawa N; Sasaki K; Chazono H; Hanazawa T; Okamoto Y; Seki N
Int J Cancer; 2008 Oct; 123(8):1816-23. PubMed ID: 18661521
[TBL] [Abstract][Full Text] [Related]
13. Three distinct genomic subtypes of head and neck squamous cell carcinoma associated with clinical outcomes.
Lee DJ; Eun YG; Rho YS; Kim EH; Yim SY; Kang SH; Sohn BH; Kwon GH; Lee JS
Oral Oncol; 2018 Oct; 85():44-51. PubMed ID: 30220319
[TBL] [Abstract][Full Text] [Related]
14. Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets.
Shen Y; Liu J; Zhang L; Dong S; Zhang J; Liu Y; Zhou H; Dong W
Biomed Res Int; 2019; 2019():7376034. PubMed ID: 31485443
[TBL] [Abstract][Full Text] [Related]
15. A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma.
Cao W; Liu JN; Liu Z; Wang X; Han ZG; Ji T; Chen WT; Zou X
Oral Oncol; 2017 Feb; 65():94-101. PubMed ID: 28109476
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.
Tawk B; Schwager C; Deffaa O; Dyckhoff G; Warta R; Linge A; Krause M; Weichert W; Baumann M; Herold-Mende C; Debus J; Abdollahi A
Radiother Oncol; 2016 Feb; 118(2):350-8. PubMed ID: 26711490
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics-based discovery of PYGM and TNNC2 as potential biomarkers of head and neck squamous cell carcinoma.
Jin Y; Yang Y
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31324732
[TBL] [Abstract][Full Text] [Related]
18. A gene signature associated with prognosis and immune processes in head and neck squamous cell carcinoma.
Bai S; Zhang P; Zhang JC; Shen J; Xiang X; Yan YB; Xu ZQ; Zhang J; Long L; Wang C; Shi P; Yang L; Chen W; Liu H
Head Neck; 2019 Aug; 41(8):2581-2590. PubMed ID: 30839132
[TBL] [Abstract][Full Text] [Related]
19. A key genomic signature associated with lymphovascular invasion in head and neck squamous cell carcinoma.
Zhang J; Lin H; Jiang H; Jiang H; Xie T; Wang B; Huang X; Lin J; Xu A; Li R; Zhang J; Yuan Y
BMC Cancer; 2020 Mar; 20(1):266. PubMed ID: 32228488
[TBL] [Abstract][Full Text] [Related]
20. Identification of 4-lncRNA prognostic signature in head and neck squamous cell carcinoma.
Diao P; Song Y; Ge H; Wu Y; Li J; Zhang W; Wang Y; Cheng J
J Cell Biochem; 2019 Jun; 120(6):10010-10020. PubMed ID: 30548328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
